array:22 [
  "pii" => "S0001731014700146"
  "issn" => "00017310"
  "doi" => "10.1016/S0001-7310(14)70014-6"
  "estado" => "S300"
  "fechaPublicacion" => "2014-10-01"
  "aid" => "70014"
  "copyright" => "Academia Española de Dermatología y Venereología"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "subdocumento" => "fla"
  "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:9-20"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1123
    "formatos" => array:3 [
      "EPUB" => 36
      "HTML" => 327
      "PDF" => 760
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "S0001731014700158"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(14)70015-8"
    "estado" => "S300"
    "fechaPublicacion" => "2014-10-01"
    "aid" => "70015"
    "copyright" => "Academia Española de Dermatología y Venereología"
    "documento" => "article"
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:21-33"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 770
      "formatos" => array:3 [
        "EPUB" => 32
        "HTML" => 273
        "PDF" => 465
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "IL-17 and IL-17R: an auspicious therapeutic target for psoriatic disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "21"
          "paginaFinal" => "33"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "IL-17 e IL-17R: una diana terapéutica favorable para la enfermedad psoriásica"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A. Mitra, S.K. Raychaudhuri, S.P. Raychaudhuri"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "A."
              "apellidos" => "Mitra"
            ]
            1 => array:2 [
              "nombre" => "S.K."
              "apellidos" => "Raychaudhuri"
            ]
            2 => array:2 [
              "nombre" => "S.P."
              "apellidos" => "Raychaudhuri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700158?idApp=UINPBA000044"
    "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700158/v1_201411120051/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S0001731014700134"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(14)70013-4"
    "estado" => "S300"
    "fechaPublicacion" => "2014-10-01"
    "aid" => "70013"
    "copyright" => "Academia Española de Dermatología y Venereología"
    "documento" => "simple-article"
    "subdocumento" => "edi"
    "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:6-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 460
      "formatos" => array:3 [
        "EPUB" => 28
        "HTML" => 245
        "PDF" => 187
      ]
    ]
    "en" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "IL-17 in psoriasis. The final frontier or just another brick in the wall?"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "6"
          "paginaFinal" => "8"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J.M. Carrascosa, L. Puig"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J.M."
              "apellidos" => "Carrascosa"
            ]
            1 => array:2 [
              "nombre" => "L."
              "apellidos" => "Puig"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700134?idApp=UINPBA000044"
    "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700134/v1_201411120051/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "Pathogenic role of IL-17 in psoriasis and psoriatic arthritis"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "9"
        "paginaFinal" => "20"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A. Chiricozzi"
        "autores" => array:1 [
          0 => array:2 [
            "nombre" => "A."
            "apellidos" => "Chiricozzi"
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:2 [
            "entidad" => "Department of Dermatology, University of Rome Tor Vergata, Rome, Italy"
            "identificador" => "aff0005"
          ]
          1 => array:2 [
            "entidad" => "Laboratory for Investigative Dermatology, The Rockefeller University, New York, USA"
            "identificador" => "aff0010"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Papel patógeno de la IL-17 en la psoriasis y en la artritis psoriásica"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec360878"
          "palabras" => array:8 [
            0 => "IL-17"
            1 => "Psoriasis"
            2 => "Arthritis"
            3 => "Secukinumab"
            4 => "Ixekizumab"
            5 => "Brodalumab"
            6 => "Atherosclerosis"
            7 => "Obesity"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec360879"
          "palabras" => array:8 [
            0 => "IL-17"
            1 => "Psoriasis"
            2 => "Artritis"
            3 => "Secukinumab"
            4 => "Ixekizumab"
            5 => "Brodalumab"
            6 => "Aterosclerosis"
            7 => "Obesidad"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Psoriasis is a chronic inflammatory skin disorder resulting from a complex network of cytokines and chemokines produced by various immune cell types and tissue cells&#46; Emerging evidence suggests a central role of IL-17 and IL-23&#47;T17 axis in the pathogenesis of psoriasis&#44; giving a rationale for using IL-17-blocking agents as therapeutics&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Three agents targeting IL-17 signaling are being studied in Phase III clinical trials&#58; secukinumab and ixekizumab &#40;IL-17 neutralizing agents&#41;&#44; and brodalumab &#40;IL-17 receptor antagonist&#41;&#46; Preliminary results are highly promising for all anti-IL17 agents&#44; creating fair expectations on this class of agents as the new effective therapeutic approach for the treatment of psoriasis&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La psoriasis es un trastorno cr&#243;nico inflamatorio de la piel resultante de un complejo sistema de citocinas y quimiocinas producidas por varios tipos de c&#233;lulas inmunes y c&#233;lulas tisulares&#46; La evidencia incipiente sugiere un papel central de la IL-17 y el eje IL-23&#47;T17 en la patog&#233;nesis de la psoriasis&#44; lo que ofrece una base para el uso de agentes bloqueadores de la IL-17 como tratamiento&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Est&#225;n siendo estudiados en estudios cl&#237;nicos en fase III tres agentes enfocados en la se&#241;alizaci&#243;n de la IL-17&#58; secukinumab e ixekizumab &#40;agentes neutralizantes de la IL-17&#41;&#44; y brodalumab &#40;antagonista del receptor de la IL-17&#41;&#46; Los resultados preliminares son altamente prometedores para todos los agentes anti-IL17&#44; lo que crea claras expectativas para esta clase de agentes como un nuevo planteamiento terap&#233;utico eficaz para el tratamiento de la psoriasis&#46;</p>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6148"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700146?idApp=UINPBA000044"
]
Share
Journal Information

Statistics

Follow this link to access the full text of the article

Pathogenic role of IL-17 in psoriasis and psoriatic arthritis
Papel patógeno de la IL-17 en la psoriasis y en la artritis psoriásica
A. Chiricozzi
Department of Dermatology, University of Rome Tor Vergata, Rome, Italy
Laboratory for Investigative Dermatology, The Rockefeller University, New York, USA
Read
5215
Times
was read the article
2821
Total PDF
2394
Total HTML
Share statistics
 array:22 [
  "pii" => "S0001731014700146"
  "issn" => "00017310"
  "doi" => "10.1016/S0001-7310(14)70014-6"
  "estado" => "S300"
  "fechaPublicacion" => "2014-10-01"
  "aid" => "70014"
  "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
  "copyrightAnyo" => "2014"
  "documento" => "article"
  "subdocumento" => "fla"
  "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:9-20"
  "abierto" => array:3 [
    "ES" => true
    "ES2" => true
    "LATM" => true
  ]
  "gratuito" => true
  "lecturas" => array:2 [
    "total" => 1123
    "formatos" => array:3 [
      "EPUB" => 36
      "HTML" => 327
      "PDF" => 760
    ]
  ]
  "itemSiguiente" => array:17 [
    "pii" => "S0001731014700158"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(14)70015-8"
    "estado" => "S300"
    "fechaPublicacion" => "2014-10-01"
    "aid" => "70015"
    "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
    "documento" => "article"
    "subdocumento" => "fla"
    "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:21-33"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 770
      "formatos" => array:3 [
        "EPUB" => 32
        "HTML" => 273
        "PDF" => 465
      ]
    ]
    "en" => array:10 [
      "idiomaDefecto" => true
      "titulo" => "IL-17 and IL-17R&#58; an auspicious therapeutic target for psoriatic disease"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "tieneResumen" => array:2 [
        0 => "en"
        1 => "es"
      ]
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "21"
          "paginaFinal" => "33"
        ]
      ]
      "titulosAlternativos" => array:1 [
        "es" => array:1 [
          "titulo" => "IL-17 e IL-17R&#58; una diana terap&#233;utica favorable para la enfermedad psori&#225;sica"
        ]
      ]
      "contieneResumen" => array:2 [
        "en" => true
        "es" => true
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "A&#46; Mitra, S&#46;K&#46; Raychaudhuri, S&#46;P&#46; Raychaudhuri"
          "autores" => array:3 [
            0 => array:2 [
              "nombre" => "A&#46;"
              "apellidos" => "Mitra"
            ]
            1 => array:2 [
              "nombre" => "S&#46;K&#46;"
              "apellidos" => "Raychaudhuri"
            ]
            2 => array:2 [
              "nombre" => "S&#46;P&#46;"
              "apellidos" => "Raychaudhuri"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700158?idApp=UINPBA000044"
    "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700158/v1_201411120051/en/main.assets"
  ]
  "itemAnterior" => array:17 [
    "pii" => "S0001731014700134"
    "issn" => "00017310"
    "doi" => "10.1016/S0001-7310(14)70013-4"
    "estado" => "S300"
    "fechaPublicacion" => "2014-10-01"
    "aid" => "70013"
    "copyright" => "Academia Espa&#241;ola de Dermatolog&#237;a y Venereolog&#237;a"
    "documento" => "simple-article"
    "subdocumento" => "edi"
    "cita" => "Actas Dermosifiliogr. 2014;105 Supl 1:6-8"
    "abierto" => array:3 [
      "ES" => true
      "ES2" => true
      "LATM" => true
    ]
    "gratuito" => true
    "lecturas" => array:2 [
      "total" => 460
      "formatos" => array:3 [
        "EPUB" => 28
        "HTML" => 245
        "PDF" => 187
      ]
    ]
    "en" => array:7 [
      "idiomaDefecto" => true
      "titulo" => "IL-17 in psoriasis&#46; The final frontier or just another brick in the wall&#63;"
      "tienePdf" => "en"
      "tieneTextoCompleto" => 0
      "paginas" => array:1 [
        0 => array:2 [
          "paginaInicial" => "6"
          "paginaFinal" => "8"
        ]
      ]
      "contienePdf" => array:1 [
        "en" => true
      ]
      "autores" => array:1 [
        0 => array:2 [
          "autoresLista" => "J&#46;M&#46; Carrascosa, L&#46; Puig"
          "autores" => array:2 [
            0 => array:2 [
              "nombre" => "J&#46;M&#46;"
              "apellidos" => "Carrascosa"
            ]
            1 => array:2 [
              "nombre" => "L&#46;"
              "apellidos" => "Puig"
            ]
          ]
        ]
      ]
    ]
    "idiomaDefecto" => "en"
    "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700134?idApp=UINPBA000044"
    "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700134/v1_201411120051/en/main.assets"
  ]
  "en" => array:11 [
    "idiomaDefecto" => true
    "titulo" => "Pathogenic role of IL-17 in psoriasis and psoriatic arthritis"
    "tieneTextoCompleto" => 0
    "paginas" => array:1 [
      0 => array:2 [
        "paginaInicial" => "9"
        "paginaFinal" => "20"
      ]
    ]
    "autores" => array:1 [
      0 => array:3 [
        "autoresLista" => "A&#46; Chiricozzi"
        "autores" => array:1 [
          0 => array:2 [
            "nombre" => "A&#46;"
            "apellidos" => "Chiricozzi"
          ]
        ]
        "afiliaciones" => array:2 [
          0 => array:2 [
            "entidad" => "Department of Dermatology&#44; University of Rome Tor Vergata&#44; Rome&#44; Italy"
            "identificador" => "aff0005"
          ]
          1 => array:2 [
            "entidad" => "Laboratory for Investigative Dermatology&#44; The Rockefeller University&#44; New York&#44; USA"
            "identificador" => "aff0010"
          ]
        ]
      ]
    ]
    "titulosAlternativos" => array:1 [
      "es" => array:1 [
        "titulo" => "Papel pat&#243;geno de la IL-17 en la psoriasis y en la artritis psori&#225;sica"
      ]
    ]
    "pdfFichero" => "main.pdf"
    "tienePdf" => true
    "PalabrasClave" => array:2 [
      "en" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Keywords"
          "identificador" => "xpalclavsec360878"
          "palabras" => array:8 [
            0 => "IL-17"
            1 => "Psoriasis"
            2 => "Arthritis"
            3 => "Secukinumab"
            4 => "Ixekizumab"
            5 => "Brodalumab"
            6 => "Atherosclerosis"
            7 => "Obesity"
          ]
        ]
      ]
      "es" => array:1 [
        0 => array:4 [
          "clase" => "keyword"
          "titulo" => "Palabras clave"
          "identificador" => "xpalclavsec360879"
          "palabras" => array:8 [
            0 => "IL-17"
            1 => "Psoriasis"
            2 => "Artritis"
            3 => "Secukinumab"
            4 => "Ixekizumab"
            5 => "Brodalumab"
            6 => "Aterosclerosis"
            7 => "Obesidad"
          ]
        ]
      ]
    ]
    "tieneResumen" => true
    "resumen" => array:2 [
      "en" => array:2 [
        "titulo" => "Abstract"
        "resumen" => "<p id="spar0005" class="elsevierStyleSimplePara elsevierViewall">Psoriasis is a chronic inflammatory skin disorder resulting from a complex network of cytokines and chemokines produced by various immune cell types and tissue cells&#46; Emerging evidence suggests a central role of IL-17 and IL-23&#47;T17 axis in the pathogenesis of psoriasis&#44; giving a rationale for using IL-17-blocking agents as therapeutics&#46;</p><p id="spar0010" class="elsevierStyleSimplePara elsevierViewall">Three agents targeting IL-17 signaling are being studied in Phase III clinical trials&#58; secukinumab and ixekizumab &#40;IL-17 neutralizing agents&#41;&#44; and brodalumab &#40;IL-17 receptor antagonist&#41;&#46; Preliminary results are highly promising for all anti-IL17 agents&#44; creating fair expectations on this class of agents as the new effective therapeutic approach for the treatment of psoriasis&#46;</p>"
      ]
      "es" => array:2 [
        "titulo" => "Resumen"
        "resumen" => "<p id="spar0015" class="elsevierStyleSimplePara elsevierViewall">La psoriasis es un trastorno cr&#243;nico inflamatorio de la piel resultante de un complejo sistema de citocinas y quimiocinas producidas por varios tipos de c&#233;lulas inmunes y c&#233;lulas tisulares&#46; La evidencia incipiente sugiere un papel central de la IL-17 y el eje IL-23&#47;T17 en la patog&#233;nesis de la psoriasis&#44; lo que ofrece una base para el uso de agentes bloqueadores de la IL-17 como tratamiento&#46;</p><p id="spar0020" class="elsevierStyleSimplePara elsevierViewall">Est&#225;n siendo estudiados en estudios cl&#237;nicos en fase III tres agentes enfocados en la se&#241;alizaci&#243;n de la IL-17&#58; secukinumab e ixekizumab &#40;agentes neutralizantes de la IL-17&#41;&#44; y brodalumab &#40;antagonista del receptor de la IL-17&#41;&#46; Los resultados preliminares son altamente prometedores para todos los agentes anti-IL17&#44; lo que crea claras expectativas para esta clase de agentes como un nuevo planteamiento terap&#233;utico eficaz para el tratamiento de la psoriasis&#46;</p>"
      ]
    ]
  ]
  "idiomaDefecto" => "en"
  "url" => "/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.assets"
  "Apartado" => array:4 [
    "identificador" => "6148"
    "tipo" => "SECCION"
    "en" => array:2 [
      "titulo" => "Editorial"
      "idiomaDefecto" => true
    ]
    "idiomaDefecto" => "en"
  ]
  "PDF" => "https://static.elsevier.es/multimedia/00017310/00000105000000S1/v1_201411120051/S0001731014700146/v1_201411120051/en/main.pdf?idApp=UINPBA000044&text.app=https://actasdermo.org/"
  "EPUB" => "https://multimedia.elsevier.es/PublicationsMultimediaV1/item/epub/S0001731014700146?idApp=UINPBA000044"
]
Article information
ISSN: 00017310
Original language: English
The statistics are updated each day
Year/Month Html Pdf Total
2024 November 4 4 8
2024 October 44 45 89
2024 September 38 36 74
2024 August 67 75 142
2024 July 47 32 79
2024 June 66 61 127
2024 May 38 40 78
2024 April 38 52 90
2024 March 43 36 79
2024 February 32 42 74
2024 January 24 35 59
2023 December 42 40 82
2023 November 35 44 79
2023 October 29 25 54
2023 September 46 33 79
2023 August 21 19 40
2023 July 33 42 75
2023 June 32 20 52
2023 May 47 34 81
2023 April 33 38 71
2023 March 22 38 60
2023 February 26 25 51
2023 January 25 25 50
2022 December 35 22 57
2022 November 26 20 46
2022 October 33 13 46
2022 September 25 35 60
2022 August 39 28 67
2022 July 29 34 63
2022 June 20 24 44
2022 May 41 45 86
2022 April 43 23 66
2022 March 49 57 106
2022 February 26 28 54
2022 January 40 51 91
2021 December 38 53 91
2021 November 28 43 71
2021 October 32 46 78
2021 September 34 49 83
2021 August 19 27 46
2021 July 43 47 90
2021 June 26 42 68
2021 May 31 55 86
2021 April 89 84 173
2021 March 50 44 94
2021 February 24 30 54
2021 January 29 18 47
2020 December 33 26 59
2020 November 30 29 59
2020 October 18 19 37
2020 September 29 25 54
2020 August 38 42 80
2020 July 37 26 63
2020 June 42 42 84
2020 May 47 35 82
2020 April 52 35 87
2020 March 54 22 76
2020 February 6 1 7
2019 December 0 2 2
2019 February 0 2 2
2018 December 0 2 2
2018 September 0 2 2
2018 April 0 3 3
2018 March 2 5 7
2018 February 14 34 48
2018 January 24 24 48
2017 December 14 23 37
2017 November 32 30 62
2017 October 19 27 46
2017 September 13 27 40
2017 August 11 17 28
2017 July 19 35 54
2017 June 22 24 46
2017 May 19 29 48
2017 April 15 40 55
2017 March 20 48 68
2017 February 10 24 34
2017 January 12 47 59
2016 December 11 20 31
2016 November 24 27 51
2016 October 26 37 63
2016 September 0 2 2
2016 July 4 14 18
2016 June 0 13 13
2016 May 0 6 6
2016 April 0 10 10
2016 March 0 15 15
2016 February 0 19 19
2016 January 0 16 16
2015 December 0 7 7
2015 November 0 28 28
2015 October 0 21 21
2015 September 0 34 34
2015 August 0 25 25
2015 July 0 1 1
2015 June 0 8 8
2015 May 0 3 3
2015 April 1 2 3
2015 March 2 5 7
2015 February 7 1 8
2015 January 2 1 3
2014 December 2 0 2
2014 November 2 0 2
Show all

Follow this link to access the full text of the article

Idiomas
Actas Dermo-Sifiliográficas
es en

¿Es usted profesional sanitario apto para prescribir o dispensar medicamentos?

Are you a health professional able to prescribe or dispense drugs?